$69.99
1.14% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US3795772082
Symbol
GMED
Sector

Globus Medical, Inc. Class A Stock price

$69.99
+0.94 1.36% 1M
+15.50 28.45% 6M
+16.70 31.34% YTD
+16.18 30.07% 1Y
-13.70 16.37% 3Y
+20.44 41.25% 5Y
+51.05 269.54% 10Y
NYSE, Closing price Fri, Sep 06 2024
-0.81 1.14%
ISIN
US3795772082
Symbol
GMED
Sector

Key metrics

Market capitalization $9.48b
Enterprise Value $9.52b
P/E (TTM) P/E ratio 236.37
EV/FCF (TTM) EV/FCF 59.09
EV/Sales (TTM) EV/Sales 4.25
P/S ratio (TTM) P/S ratio 4.24
P/B ratio (TTM) P/B ratio 2.38
Revenue growth (TTM) Revenue growth 103.89%
Revenue (TTM) Revenue $2.24b
EBIT (operating result TTM) EBIT $181.16m
Free Cash Flow (TTM) Free Cash Flow $161.02m
Cash position $492.93m
EPS (TTM) EPS $0.30
P/E forward 77.40
P/S forward 3.82
EV/Sales forward 3.83
Short interest 4.35%
Show more

Is Globus Medical, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Globus Medical, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Globus Medical, Inc. Class A forecast:

10x Buy
63%
6x Hold
38%

Analyst Opinions

16 Analysts have issued a Globus Medical, Inc. Class A forecast:

Buy
63%
Hold
38%

Financial data from Globus Medical, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,237 2,237
104% 104%
100%
- Direct Costs 1,004 1,004
233% 233%
45%
1,233 1,233
55% 55%
55%
- Selling and Administrative Expenses 660 660
68% 68%
30%
- Research and Development Expense 164 164
104% 104%
7%
409 409
27% 27%
18%
- Depreciation and Amortization 227 227
222% 222%
10%
EBIT (Operating Income) EBIT 181 181
28% 28%
8%
Net Profit 41 41
80% 80%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Globus Medical, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Globus Medical, Inc. Class A Stock News

Neutral
GlobeNewsWire
17 days ago
AUDUBON, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the ADIRA™ XLIF™ Plate System, the Company's first product launch compatible across its expanded lateral interbody portfolio.
Neutral
GlobeNewsWire
19 days ago
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Globus Medical, Inc. (“Globus” or the “Company”) (NYSE:GMED) on behalf of Globus stockholders. Our investigation concerns whether Globus has violated the federal securities laws and/or engaged in other unlawful business practices.
Neutral
Accesswire
19 days ago
NEW YORK CITY, NY / ACCESSWIRE / August 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globus Medical, Inc. ("Globus Medical" or "the Company") (NYSE:GMED). Investors who purchased Globus Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GMED.
More Globus Medical, Inc. Class A News

Company Profile

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Head office United States
CEO Daniel Scavilla
Employees 5,000
Founded 2003
Website www.globusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today